Stroke

Study shows hemophilia drug helps bleeding stroke patients

Published in Managed Care Business Week, March 15th, 2005

A drug that keeps hemophiliacs from bleeding to death could also prove to be the first treatment for the most lethal and crippling type of stroke, the kind caused by a burst blood vessel in the brain.

In a promising international study, stroke victims given the drug were one-third less likely to die and 3 times more likely to survive without severe disability.

"What was really startling was how well this drug worked," said Stephan Mayer, MD, a stroke specialist at the Columbia University Medical Center in New York who led the study. "I was fairly amazed."

The drug needs more study, and Mayer said it will be at least 2 years before...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Managed Care Business Week

Source: Managed Care Business Week (2005-03-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry